The risk of human immunodeficiency virus-1 infection in twin pairs born to infected mothers in Africa

Journal of Infectious Diseases

Volumn 188, Issue 6, 2003, Pages 850-855

  Biggar, Robert J ^a,g   Cassol, Sharon ^d,f   Kumwenda, Newton ^e   Lema, Valentino ^e   Janes, Michelle ^d   Pilon, Richard ^d   Senzani, Vincent ^e   Yellin, Frances ^b   Taha, Taha E T ^c   Broadhead, Robin L ^e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Computer Science Corporation ^*  (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF OTTAWA   (Canada)

^e UNIVERSITY OF MALAWI   (Malawi)

^f UNIVERSITY OF KWAZULU NATAL   (South Africa)

^g NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; ARTICLE; BIRTH ORDER; CESAREAN SECTION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DELIVERY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MOTHER; NEWBORN; PERINATAL INFECTION; POLYMERASE CHAIN REACTION; POSTNATAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; STRATIFICATION; TWINS; VAGINAL DELIVERY; VIRUS TRANSMISSION;

AFRICA; BIRTH ORDER; CESAREAN SECTION; DELIVERY, OBSTETRIC; DISEASE TRANSMISSION, VERTICAL; DISEASES IN TWINS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY, MULTIPLE; RISK FACTORS; TWINS;

EID: 0141617475     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/377584     Document Type: Article

References (33)

1. Simonon A, Lepage P, Karita E, et al. An assessment of the timing of mother-to-child transmission of human immunodeficiency virus type I by means of polymerase chain reaction. J Acquir Immune Defic Syndr 1994; 7:952-7.
2. Biggar RJ, Miotti PG, Taha TE, et al. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet 1996; 347:1647-50.
3. Bertolli J, St. Louis ME, Simonds RJ, et al. Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast-feeding population in Kinshasa, Zaire. J Infect Dis 1996; 174:722-6.
4. Dunn DT, Brandt CD, Krivine A, et al. The sensitivity of HIV-1 DNA polymerase chair reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS 1995; 9:F7-11.
5. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 B - a meta-analysis of 15 prospective studies. The International Perinatal HIV-1 Group. N Engl J Med 1999; 340:977-87.
6. Elective caesarian-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomized clinical trial. The European Mode of Delivery Collaboration. Lancet 1999; 353:1035-9.
7. Mofenson LM. A critical review of studies evaluating the relationship of mode of delivery to perinatal transmission of human immunodeficiency virus. Pediatr Infect Dis J 1995; 14:169-76.
8. Ioannidis JP, Abrams EJ, Ammann A, et al. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/mL. J Infect Dis 2001; 183:539-45.
9. Goedert JJ, Duliège AM, Amos CI, Felton S, Biggar RJ. High risk of HIV-1 infection for first-born twins: the International Registry of HIV-exposed Twins. Lancet 1991; 338:1471-5.
10. Duliège AM, Amos CI, Felton S, Biggar RJ, Goedert JJ. Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. International Registry of HIV-Exposed Twins. J Pediatr 1995; 126:625-32.
11. Gaillard P, Mwanyumba F, Verhofstede C, et al. Vaginal lavage with chlorhexidine during labor to reduce mother-to-child HIV transmission: clinical trial in Mombassa, Kenya. AIDS 2001; 15:389-96.
12. Dabis F, Leroy V, Castetbon K, Spira R, Newell ML, Salamon R. Preventing mother-to-child transmission of HIV-1 in Africa in the year 2000. AIDS 2000; 14:1017-2.
13. Biggar RJ, Miley W, Miotti P, et al. Blood collection on filter paper: a practical approach to sample collection for studies of perinatal HIV transmission. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:368-73.
14. Biggar RJ, Janes M, Pilon R, et al. Virus levels in untreated African infants infected with human immunodeficiency virus type 1. J Infect Dis 1999; 180:1838-43.
15. Biggar RJ, Broadhead R, Cormier M, Kumwenda N, Taha TE, Cassol S. Virus levels in newborn African infants undergoing primary HIV-1 infection. AIDS 2001; 15:1311-13.
16. Biggar RJ, Janes M, Pilon R, et al. Human immunodeficiency virus type 1 infection in twin pairs infected at birth. J Infect Dis 2002; 186:281-5.
17. Reisler RB, Thea DM, Pliner V, et al. Early detection of reverse transcriptase activity in plasma of neonates infected with HIV-1: a comparative analysis with RNA-based and DNA-based testing using polymerase chain reaction. J Acquir Immune Defic Syndr 2001; 26:93-102.
18. Miotti PG, Taha TE, Kumwenda NI, et al. HIV transmission through breastfeeding: a study in Malawi. JAMA 1999; 282:781-3.
19. Landesman SH, Kalish LA, Burns DN, et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study. N Engl J Med 1996; 334:1617-23.
20. Mandelbrot L, Mayaux MJ, Bongain A, et al. Obstetrical factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. Am J Obstet Gynecol 1996; 175:661-7.
21. Tess BH, Rodrigues LC, Newell ML, Dunn DT, Lago TD. Breastfeeding, genetic, obstetric and other risk factors associated with mother-to-child transmission of HIV-1 in Sao Paulo State, Brazil. Sao Paulo Collaborative Study for Vertical Transmission of HIV-1. AIDS 1998; 12:513-20.
22. Livingston EG. Management of HIV in pregnancy. Curr Womens Health Rep 2002; 2:245-52.
23. Krist AH, Crawford-Faucher A. Management of newborns exposed to maternal HIV infection. Am Fam Physician 2002; 65:2049-56.
24. Bowles WA. Clinical aspects of normal and abnormal labor. In: Creasy RK, Resnik R, eds. Maternal fetal medicine: principles and practice. 3rd ed. Philadelphia: WB Saunders, 1994:527-57.
25. O'Donovan D, Ariyoshi K, Milligan P, et al. Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. AIDS 2000; 14:441-8.
26. Chuachoowong R, Shaffer N, Siriwasin W, et al. Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. Bangkok Collaborative Perinatal HIV Transmission Study Group. J Infect Dis 2000; 181:99-106.
27. Goedert JJ, Mendez H, Drummond JE, et al. Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gp120. Lancet 1989; 2:1351-4.
28. Shapiro DE, Sperling RS, Mandelbrot L, Britto P, Cunningham BE. Risk factors for perinatal human immunodeficiency virus transmission in patients receiving zidovudine prophylaxis. Pediatric AIDS Clinical Trials Group protocol 076 Study Group. Obstet Gynecol 1999; 94:897-908.
29. Garcia PM, Kalish LA, Pitt J, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med 1999; 341:394-402.
30. Ait-Khaled M, Lyall EG, Stainsby C, et al. Intrapartum mucosal exposure to human immunodeficiency virus type 1 (HIV-1) of infants born to HIV-1-infected mothers correlates with maternal plasma virus burden. J Infect Dis 1998; 177:1097-100.
31. Marcollet A, Goffinet F, Firtion G, et al. Differences in postpartum morbidity in women who are infected with the human immunodeficiency virus after elective cesarean delivery, emergency cesarean delivery, or vaginal delivery. Am J Obstet Gynecol 2002; 186:784-9.
32. Nduati R, Richardson BA, John G, et al. Effect of breastfeeding on mortality among HIV-1 infected women: a randomised trial. Lancet 2001; 357:1651-5.
33. Fiscus SA, Adimora AA, Funk ML. Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North Carolina. Pediatr Infect Dis J 2002; 21:664-8.